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ABSTRACT
Aim: To evaluate the differences between ganglion cell
complex (GCC) of primary open angle glaucoma and
ocular disorders affecting the macula.
Methods and Materials: Forty-seven patients diagnosed
with primary open angle glaucoma and 27 patients with
macular diseases of different aetiology were enrolled in
this pilot study. All patients underwent direct GCC
analysis with the optical coherence tomographic scan,
using the Optovue Fourier Domain RTVue-version. A
comparison of the average GCC thickness, focal loss
volume (FLV) and the global loss volume (GLV) of the
two groups was made.
Results: A total of 74 pairs of eyes were included in the
study. This comprised 48 males and 26 females with a
mean age of 53.8 ± 11.3 among glaucoma patients and
59.8 ± 9.8 among patients with macular disease. Eyes
with macular disease (33.3%) and eyes with glaucoma
(42.6%) had abnormal average GCC parameters.
However, the mean average GCC value was
significantly higher in eyes with macular disease (87.50
± 20.73) when compared with eyes with glaucoma (76.55
± 12.51) (p=0.01). A significantly higher percentage of
eyes with macular disease (43.3%) had GLV values
within normal range when compared with eyes with
glaucoma (21.3%) (p=0.03). Abnormal FLV values were
seen in both eyes with macular disease (83.3%) and eyes
with glaucoma (80.9%) but the differences were not of
statistical significance (p= 0.24).
Conclusion: This pilot study demonstrated abnormal OCT
GCC values in eyes with glaucoma as well as in eyes
with macular disease. However, eyes with macular
disease had significantly higher mean average GCC
parameters but GLV parameters that were within
normal values.
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INTRODUCTION
One of the leading causes of blindness worldwide is
glaucoma, an optic neuropathy characterized by progressive
loss of optic nerve function. Glaucoma affects 3 main areas
in the eyes, the optic nerve head, nerve fibre layer and retinal
ganglion cells. Retinal ganglion cells encompass three layers
in the retina: 1) the retinal nerve fibre layer (NFL) made up
of ganglion cell axons, 2) the ganglion cell layer (GCL) made
up of ganglion cell bodies, and 3) the inner-plexiform layer
(IPL) made up of the ganglion cell dendrites. All three layers,
collectively known as the ganglion cell complex (GCC),
become thinner as the ganglion cells die from glaucoma.  1
The GCC is now increasingly being evaluated for early
glaucomatous changes.  Structural changes in the optic nerve1
head and retinal nerve fibre layer also occur.  New2,3
diagnostic tools for glaucoma focus on providing
quantitative, reproducible, and objective measurements of
optic nerve head, retinal nerve fibre layer (RNFL) thickness
and GCC. Some of these new investigational tools include
confocal scanning laser ophthalmoscopy (CSLO), scanning
laser polarimetry (SLP), and optical coherence tomography
(OCT).  Of the three tools, the OCT was found to have4
significantly better diagnostic accuracy.
Optical coherence tomography (OCT) is a non invasive
and relatively safe imaging technique valuable for analysis
of the optic nerve head and the retinal nerve fibre layer in
glaucoma. It is also valuable for evaluating the retinal
anatomy in several macular diseases, including macular
hole, age-related macular degeneration and macular oedema.
OCT provides high resolution and reproducible images of
the RNFL that discriminate glaucomatous from healthy
subjects.  Ganglion cell loss is best analysed around the5, 6, 7
macular region as it contains about 50% of all retinal
ganglion cells. However, the GCC is also affected in various
disorders affecting the retina. For instance, Cabrera DeBuc D
et al found reduced thickness of ganglion cell/inner
plexiform layer (GCL+IPL) complex in the pericentral region
of the macula in eyes with mild diabetic retinopathy.  8
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The RTVue, a recent Fourier-domain OCT from
Optovue, directly measures the thickness of the 3 layers that
constitute the GCC and provides a unique analysis of the
percentage loss of these layers compared to an extensive
normative database. The high depth resolution available in
the RTVue enables a complete separation of the GCC from
other areas and enables better analysis. GCC analysis has
been found to significantly correlate with visual field
damage and can accurately distinguish between normal and
glaucomatous eyes.  Anecdotal evidence also suggests that8, 9
the GCC may manifest damage before the peri-papillary
RNFL measurements, however this possibility requires
further clinical validation and studies.
Focal loss volume (FLV) and global loss volume (GLV)
are two important diagnostic tools available on the version
4 soft ware of the RTVue and are suggested to provide the
most sensitive detection of GCC thinning.  FLV provides a10
quantitative measure of the amount of significant GCC loss.
It is the total sum of significant GCC loss (in volume)
divided by the map area, as such it provides the percentage
of significant tissue loss for volume. Early study results
suggest that FLV is the most accurate parameter to
differentiate normal from glaucomatous eyes, being better
than the average GCC thickness parameter.  10
Few studies have evaluated the effect of diseases of the
macula on GCC parameters. Based on the above evidence,
this study designed a pilot study to investigate the OCT
GCC characteristics for both glaucoma and different macular
diseases. The FLV, GLV and Av GCC parameters were
measured for both groups of eyes and a comparison was
made. 
AIM 
To evaluate the differences between ganglion cell complex
parameters in primary open angle glaucoma and ocular
disorders affecting the macula.
METHODS AND MATERIALS
Forty-seven patients who had been diagnosed with primary
open angle glaucoma and 27 patients with macular diseases
of different aetiology between January and December 2009
were enrolled in this study. All patients underwent direct
ganglion cell (GCC) analysis with the optical coherence
tomographic scans, using the Optovue Fourier Domain
RTVue-version. The RTVue-100 (Optovue, Inc., Fremont,
CA) with software version 2.0.4.0, uses a scanning laser
diode to emit a scan beam with a wavelength of 820 nm to
provide images of ocular microstructures. The GCC protocol
is a 7mm raster scan composed of one horizontal B scan with
800 A scans, and 17 vertical B scans with 934 A scans. A well-
trained operator obtained good-quality OCT images with
pupillary dilation in all eyes. The criteria for determining
scan quality were signal strength of at least 50 or more (as
suggested by the manufacturer), a clear fundus image
allowing a foveal pit, even and dense colour saturation
throughout all retinal layers with red colour visible in the
retinal pigment epithelium without interruptions, and a
continuous scan pattern without missing or blank areas. As
indicated by the manufacturer, results from the scans are
colour coded; abnormal values show up in red while
borderline values are yellow, and normal values are green.
A comparison of the average GCC thickness, focal loss
volume (FLV), and global loss volume (GLV) was made
between the two groups and statistical analysis was done
with the Epi Info software. Data were presented as the mean
SD. The two-tailed paired t-test was performed to evaluate
the difference between the two groups of parameters
(macular disease and glaucoma).
RESULTS
A total of 74 pairs of eyes were included in the study. The
characteristics of the study patients are shown in table 1; 48
males and 26 females with mean ages of 53.8 ± 11.3 among
glaucoma patients, and 59.8 ± 9.8 among patients with
macular disease. Age, sex and eye affected were not
significantly different for both groups of patients. Five eyes
(18.5%) with macular disease had macular oedema
secondary to retinal vein occlusions. Another 5 eyes (18.5%)
had macular oedema secondary to diabetic retinopathy
while yet another 5 eyes (18.5%) had wet age related macular
degeneration. A further 7 eyes (26%) had macular holes and
4 eyes (14.8%) had polypoidal choroidal vasculopathy
affecting the macula. An old macular toxoplasma scar was
seen in 1 eye (3.7%). 
The mean FLV value was 9.34 ± 7.98 among eyes with
glaucoma when compared with 10.23 ± 8.18 in eyes with
macular disease. This difference was not statistically
significant (p= 0.64). The difference in the mean GLV values
between eyes with glaucoma (18.07 ± 12.86) and eyes with
macular disease (17.99 ± 13.69) was also not statistically
significant (p=0.98). Eyes with macular disease (33.3%) and
eyes with glaucoma (42.6%) had abnormal average GCC
parameters but the mean average GCC value was
significantly higher in eyes with macular disease (87.50 ±
20.73) when compared with eyes with glaucoma (76.55 ±
12.51) (p=0.01). A significantly higher percentage of eyes
with macular disease (43.3%) had GLV values within normal
range when compared with eyes with glaucoma (21.3%)
(p=0.03). Abnormal FLV values were seen in both eyes with
macular disease (83.3%) and eyes with glaucoma (80.9%), but
the differences were not of statistical significance (p= 0.24)
table 2.
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Table 1. Distribution of age, sex and the affected eye colour
Variable Glaucoma Macular disease P df P2
Frequency % Frequency %
Age
(years)
< 50 14 29.8 5 16.7 3.72 2 0.15
50 – 59 18 38.3 8 30.0 
$  60 15 31.9 14 53.3
Total 47 100 27 100 
Mean age 53.8 ± 11.3 59.8 ± 9.8
Student’s t statistic = 2.29, p = 0.03*
Sex
Male 28 59.6 20 66.7 0.39 1 0.53
Female 19 40.4 10 33.3
Total 47 100 27 100 
Affected eye
Right 26 55.3 19 633 0.48 1 0.49
Left 21 44.7 11 36.7
Total 47 100 27 100 
Table 2. Analysis of ganglion cell complex parameters in eyes
with glaucoma and macular disease
Variable Glaucoma Macular P df P2
Frequency % Frequency %
FLV 
Normal 5 10.6 5 16.7 3.08 2 0.24†
Abnormal 38 80.9 25 83.3 
Borderline 4 8.5 0 0 .0
Total 47 100.0 30 100.0
GLV 
Normal 10 21.3 13 43.3 7.17 2 0.03†*
Abnormal 27 57.4 16 53.3 
Borderline 10 21.3 1 3.3 
Total 47 100 .0 30 100.0
Average GCC 
Normal 15 31.9 16 53.3 3.82 2 0.15
Abnormal 20 42.6 10 33.3 
Borderline 12 25.5 4 13.3 
Total 47 100.0 30 100.0
†Fisher exact p, *Significant
DISCUSSION
The idea that the macula is a good site to test for
glaucomatous changes has gradually become more
acceptable over the years.  Landmark studies by Zeimer,11-16
Asrani and colleagues  have demonstrated damage in the17, 18
macula and showed that evaluation of the macula may be
more effective for detecting early glaucoma than evaluation
in the peri-papillary region. Macular evaluation for
glaucoma is centred around the GCC, which has been
reported to be damaged early in glaucoma. Selective
evaluation of the macular GCC therefore is expected to be
more sensitive for detecting glaucoma even when compared
with evaluation of the retinal nerve fibre layer (RNFL).  The19
GCC is however only abnormal in situations where
structural damage has occurred. A recent study to evaluate
the capability of Fourier-domain optical coherence
tomography (FD-OCT) to detect structural damage in
patients with preperimetric glaucoma, concluded that FD-
OCT does not seem to be decisive for early detection of
structural damage in patients with no functional
impairment.20
The concern of the present study is the effect of other
macular pathologies on GCC measurements for glaucoma.
Similar concerns have been raised about the peri-papillary
region. A recent study  showed that macular GCC21
parameters may be better diagnostic indicators in cases of
non-glaucomatous conditions with reduced RNFL thickness,
such as extensive peri-papillary atrophy in high myopia.
With this in view, this study considers that the macula area
may actually have more confounders when evaluating for
glaucoma than the peri-papillary region.
The study utilized the Optovue RTVue Fourier domain
OCT which directly measures the GCC and provides a
unique analysis of the percentage loss compared to an
extensive normative database of mixed races. The results are
presented as a significant loss from the normal, which makes
clinical interpretation straightforward. Both eyes with
glaucoma (42.6%) and eyes with macular disease (33.3%) had
abnormal average GCC values. Mean average GCC value
was higher in eyes with macular disease (87.50 ± 20.73) than
in glaucomatous eyes (76.55 ± 12.51); this difference was
statistically significant (p=0.01). Since many eyes with
macular disease had abnormal average GCC values, there
are concerns that macular disorders may be confounders of
glaucoma evaluation. However, more clinical studies are
required as this is only a pilot study.
Definite reductions in the foveal retinal nerve fibre layer
have been reported in the diabetic retina as a result of
neurodegeneration.  Macular oedema can also result in8
extensive thickening of the retina, while full thickness
macular holes affect retinal evaluation in the macula. Figure
1 shows the results of the GCC analysis carried out on one of
the patients with a macular hole. The patient examined has
a macular hole in the left eye; the corresponding GCC images
show central areas of abnormal values, the FLV and GLV
values are also abnormal even though the patient is not a
glaucoma patient. The optic nerve head analysis and TSNIT
(temporal, superior, nasal inferior, temporal direction) graph
also show that the optic nerve is not glaucomatous.
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A  B
C  D
Figure 1. Optical coherence tomographic pictures of a 52-year-old male with a macular hole in the left eye. 
A. OCT line scan of the macula; B. Ganglion cell complex significance map; C. GCC parameters revealing the abnormal FLV and
GLV values; and D. Optic nerve head map and TSNIT significance graphs. 
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Figure 2 (A to C) shows abnormal GCC significance
images in a 54-year-old female with advanced glaucoma. A
normal GCC significance map is shown in figure 2 D. The
FLV and GLV values as well as the optic nerve head map
and TSNIT curve are also grossly abnormal. In patients that
have both glaucoma and macular disease, the use of macular
GCC to evaluate the severity of glaucoma may be
misleading: both conditions can give abnormal GCC
readings, hence an erroneous impression of the severity of
the glaucoma may be given from superimposed effects of the
changes from macular disease. In other macular diseases like
macular oedema where therapeutic interventions may
improve the oedema, other OCT analytical protocols like the
grid, MM5 and line scans may be used to assess the
contribution of the macular disease to the GCC changes.




Figure 2. Optical coherence tomographic pictures of a 54-year-old female with advanced glaucoma in the right eye. 
A. Abnormal – The ganglion cell complex significance map;  B. GCC parameters revealing abnormal FLV and GLV values; C. Optic
nerve head map and TSNIT significance graphs; D GCC significance map for a normal patient.
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The focal loss volume (FLV) and global loss volume
(GLV) parameters both sum up the volume of the GCC loss
in the macula, however they give different levels of focality.
The FLV is a highly sensitive analytic tool and is able to
differentiate between glaucomatous and normal eyes as it
correlates well with the visual field index (VFI) as both
parameters are most likely influenced by visual field focal
defects.  FLV also has a higher diagnostic accuracy for22,23
perimetric glaucoma than the simple GCC average.  In this24
study results, the FLV was found to be equally abnormal in
glaucoma (80.9%) as well as in macular diseases (83.3%),
implying that this statistical tool may not be highly sensitive
in differentiating these two unique disorders. Focal volume
losses of the GCC may also occur in macular disorders. In
this study, 57.4% of eyes with glaucoma and 53.5% of eyes
with macular diseases had abnormal GLV values and this
difference was statistically significant. This may suggest that
global loss of GCC volume is more likely to be seen in
glaucoma than in macular disease.
Ganglion cell complex analysis was designed mainly to
differentiate glaucomatous from normal eyes. The literature
on the use of this tool to analyse macular disease is not rich.
As a direct consequence of this, studies comparable to this
are not easily available. Evaluating the RNFL in the region of
the macular is less sensitive for detecting glaucoma than
evaluating the GCC,  but macular disease may actually be25
a confounder when using macular GCC to evaluate
glaucomatous changes, and there may be more confounding
lesions in the macula than in the peri-papillary region or the
nerve fibre layer.
CONCLUSION
This pilot study demonstrated abnormal OCT GCC values in
eyes with glaucoma as well as in eyes with macular disease.
Eyes with macular disease showed significantly higher mean
average GCC parameters, but had GLV parameters that were
within normal values.
REFERENCES
1. Lu ATH, Wang M, Varma R, Schuman JS, Greenfield DS,
Smith SD, Huang D. Advanced imaging for Glaucoma
Study Group. Combining nerve fibre layer parameters to
optimize glaucoma diagnosis with optical coherence
tomography. Ophthalmology 2008; 115: 1352-7.
2. Harwerth RS, Carter-Dawson L, Shen F, Smith EL,
Crawford ML .Ganglion cell losses underlying visual field
defects from experimental glaucoma. Invest Ophthalmol Vis
Sci 1999; 40: 2242-2250. 
3. Somme A, Katz J, Quigley HA. Clinically detectable nerve
fibre atrophy precedes the onset of glaucomatous field
loss. Arch Ophthalmol 1991; 109: 77- 83. 
4. Greaney MJ, Hoffman DC, Garway-Heath DF, Nakla M,
Coleman AL, Caprioli J. Comparison of optic nerve
imaging methods to distinguish normal eyes from those
with glaucoma. Invest Ophthalmol Vis Sci 2002; 43: 140–145.
5. Bowd C, Weinreb RN, Williams JM, Zangwill LM. The
retinal nerve fibre layer thickness in ocular hypertensive,
normal, and glaucomatous eyes with optical coherence
tomography. Arch Ophthalmol 2000; 118: 22 -26.
6. Zangwill LM, Bowd C, Berry CC. Discriminating between
normal and glaucomatous eyes using the Heidelberg
retina tomograph, GDx nerve fibre analyser, and optical
coherence tomograph. Arch Ophthalmol 2001; 119: 985-993.
7. Williams ZY, Schuman JS, Gamell L.Optical coherence
tomography measurement of nerve fibre layer thickness
and the likelihood of a visual field defect. Am J Ophthalmol
2002; 134: 538-546.
8. Cabrera DeBuc D, Somfai GM. Early detection of retinal
thickness changes in diabetes using optical coherence
tomography. Med Sci Monit 2010; 16(3): MT15-21. 
9. Mori S, Hangai M, Nakanishi H, Kotera Y, Inoue R,
Morishita S, Aikawa Y et al. . Macular inner and total
retinal volume measurement by spectral domain optical
coherence tomography for glaucoma diagnosis. Japan
IOVS Suppl. 4651: 2008 
10. Tan O, Chopra V, Lu ATH, Schuman JS, Ishikawa H,
Wollstein G, Varma R, Huang D. Detection of macular
ganglion cell loss in glaucoma by Fourier-domain optical
coherence tomography. Ophthalmology 2009; 116:2305-
2314.
11. Tan O, Li G, Lu AT, et al. Mapping of macular
substructures with optical coherence tomography for
glaucoma diagnosis. Ophthalmology 2008; 115: 949-956.
12. Ishikawa H, Stein DM, Wollstein G, et al. Macular
segmentation with optical coherence tomography. Invest
Ophthalmol Vis Sci 2005; 46: 2012–2017.
13. Guedes V, Schuman JS, Hertzmark E, et al. Optical
coherence tomography measurement of macular and
nerve fibre layer thickness in normal and glaucomatous
human eyes. Ophthalmology 2003; 110: 177–89.
14. Medeiros FA, Zangwill LM, Bowd C, et al. Evaluation of
retinal nerve fibre layer, optic nerve head, and macular
thickness measurements for glaucoma detection using
optical coherence tomography. Am J Ophthalmol 2005; 139:
44–55.
15.  Tanito M, Itai N, Ohira A, Chihara E. Reduction of
posterior pole retinal thickness in glaucoma detected
using the retinal thickness analyser. Ophthalmology 2004;
3(2); 265–275.
16. Greenfield DS, Bagga H, Knighton RW. Macular thickness
changes in glaucomatous optic neuropathy detected using
optical coherence tomography. Archives of Ophthalmology
2003; 121(1): 41–46.
19
O Oderinlo , AO Ogunro, AO Hassan, ON Okonkwo, FO Oluyadi, M Ulaikere
17. Zeimer R, Shahidi M, Mori M, Zou S, Asrani S. A new
method for rapid mapping of the retinal thickness at the
posterior pole. Invest Ophthalmol Vis Sci 1996; 37: 1994-
2001. 
18. Zeimer R, Asrani S, Zou S, Quigley H, Jampel H.
Quantitative detection of glaucomatous damage at the
posterior pole retinal thickness mapping. A pilot study.
Ophthalmology 1998; 105: 224-231.
19. Huang D, Chakraborty S, Greenfield D, et al. Advanced
Imaging for Glaucoma Study (AIGS). National Eye
Institute (NEI) NIH 1 R01 EY013516. Poster presented at
the annual meeting of the American Academy of
Ophthalmology, New Orleans, November 2007.
20. Rolle T, Briamonte C, Curto D, Grignolo FM. Ganglion cell
complex and retinal nerve fibre layer measured by
Fourier-domain optical coherence tomography for early
detection of structural damage in patients with
preperimetric glaucoma. Clin Ophthalmol 2011; 2011(5):
961- 969. 
21. Kim NR, Lee E S, Seong GJ, Kim JH, An HG, Kim CY.
Structure-function relationship and diagnostic value of
macular ganglion cell complex measurement using
Fourier-domain OCT. Glaucoma Invest Ophthalmol Vis Sci
2010; 51(9): 4646-4651.
22. Hautenauven F, Janssen X, Pourjavan S. Correlation
between visual field index and ganglion cell complex
parameters, global loss volume and focal loss volume,
measured by RTVueTM OCT: interim analysis. Acta
Ophthalmologica 2010; 88 Suppl s246:0.
23. Lu AT, Wang M, Varma R, et al, Advanced Imaging for
Glaucoma Study Group. Combining nerve fibre layer
parameters to optimize glaucoma diagnosis with optical
coherence tomography. Ophthalmology 2008; 115: 1352–7.
24. Tan O, Chopra V, Lu Tzu-Hui A, Schuman SJ, Ishikawa H,
Wollstein G, et al. Detection of macular ganglion cell loss
in glaucoma by Fourier-domain optical coherence
tomography. Ophthalmology 2009; 116: 2305–2314.
25. Leung CK, Chan WM, Yung WH, Ng AC, Woo J, Tsang
MK, Tse RK. Comparison of macular and peri-papillary
measurements for the detection of glaucoma: An optical
coherence tomography study. Ophthalmology 2005; 3:
391–400.
20
